Full Text View
Tabular View
No Study Results Posted
Related Studies
Platelet-rich-plasma Treating Tennis Elbow
This study has been completed.
Study NCT00757289   Information provided by Biomet, Inc.
First Received: September 22, 2008   Last Updated: December 3, 2009   History of Changes

September 22, 2008
December 3, 2009
August 2007
January 2008   (final data collection date for primary outcome measure)
Visual Analog Score - Pain [ Time Frame: 4months,12 months,24months & 52 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00757289 on ClinicalTrials.gov Archive Site
  • DASH [ Time Frame: 4months,12months,24months & 52 months ] [ Designated as safety issue: No ]
  • Complications [ Time Frame: Anytime ] [ Designated as safety issue: Yes ]
Same as current
 
Platelet-rich-plasma Treating Tennis Elbow
Use of Platelet-rich-plasma to Treat Tennis Elbow, A Blinded and Randomized Single Center Study

The study is to compare the efficacy of autologous platelet concentrate injections to corticosteroid injection in patients suffering from tennis elbow with respect to pain and function.

 
 
Interventional
Allocation:  Randomized
Control:  Active Control
Endpoint Classification:  Safety/Efficacy Study
Intervention Model:  Parallel Assignment
Masking:  Double Blind (Subject, Outcomes Assessor)
Primary Purpose:  Treatment
Pain
  • Biological: PRP Injection
    PRP Injection
  • Biological: Corticosteroid Injection
    Corticosteroid Injection
  • 1: Experimental
    PRP injection
    Intervention: Biological: PRP Injection
  • 2: Active Comparator
    Corticosteroid Injection
    Intervention: Biological: Corticosteroid Injection
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
100
January 2009
January 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient with chronic epicondylitis lateralis who do not react to conservative treatment and therefore are send to the orthopedic surgeon

Exclusion Criteria:

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT00757289
Joanne Bloemsaat, Clinical Manager, Biomet Netherlands
BMET NL 03
Biomet, Inc.
 
Principal Investigator: Taco Gosens, MD Elisabeth ziekenhuis
Biomet, Inc.
December 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP